Michael A Bookman Selected Research

9-methoxyacridine

1/2002

Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael A Bookman Research Topics

Disease

35	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2002
29	Neoplasms (Cancer) 01/2022 - 01/2002
17	Ovarian Epithelial Carcinoma 01/2022 - 02/2002
15	Carcinoma (Carcinomatosis) 01/2022 - 10/2002
4	Neutropenia 01/2022 - 01/2004
4	Breast Neoplasms (Breast Cancer) 02/2009 - 01/2006
3	Ascites 12/2019 - 11/2002
2	Anemia 01/2022 - 12/2019
2	Fatigue 01/2022 - 12/2019
2	Thrombocytopenia (Thrombopenia) 12/2019 - 01/2004
2	Residual Neoplasm 12/2019 - 03/2009
2	Fallopian Tube Neoplasms 10/2013 - 09/2008
1	Nausea 12/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2014
1	Disease Progression 12/2011
1	Body Weight (Weight, Body) 12/2011
1	Hypertension (High Blood Pressure) 12/2011
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 02/2011
1	Vascular Diseases (Vascular Disease) 02/2009
1	Endometrial Neoplasms (Endometrial Cancer) 01/2009
1	Warts (Wart) 01/2009
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2006
1	Febrile Neutropenia 01/2004
1	Fever (Fevers) 11/2002

Drug/Important Bio-Agent (IBA)

22	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 02/2002
17	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2004
14	PlatinumIBA 01/2022 - 01/2002
6	Bevacizumab (Avastin)FDA Link 10/2019 - 12/2011
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2010
4	veliparibIBA 01/2022 - 12/2019
3	taxaneIBA 04/2014 - 03/2012
3	Topotecan (Hycamtin)FDA LinkGeneric 03/2009 - 11/2006
3	Gemcitabine FDA Link 03/2009 - 11/2002
3	Cisplatin (Platino)FDA LinkGeneric 01/2009 - 10/2006
2	olaparibIBA 01/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 11/2021 - 04/2014
2	liposomal doxorubicin (Doxil)FDA Link 11/2021 - 03/2009
2	IsotopesIBA 01/2021 - 12/2019
2	CreatinineIBA 01/2021 - 12/2019
2	AntigensIBA 11/2016 - 10/2002
2	Monoclonal AntibodiesIBA 12/2011 - 01/2003
2	Cytotoxins (Cytolysins)IBA 03/2009 - 02/2002
2	Hormones (Hormone)IBA 02/2009 - 08/2008
2	human ERBB2 proteinIBA 02/2009 - 01/2003
1	cediranib (AZD2171)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	1-dodecylpyridoxal (PLD)IBA 11/2021
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2019
1	Adenosine Diphosphate (ADP)IBA 12/2019
1	Platinum Compounds (Compounds, Platinum)IBA 01/2019
1	Cytidine Triphosphate (CTP)IBA 07/2017
1	Formaldehyde (Formol)FDA Link 05/2012
1	ParaffinIBA 05/2012
1	Adenosine Triphosphate (ATP)IBA 03/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2011
1	Biological ProductsIBA 02/2011
1	Aromatase InhibitorsIBA 02/2009
1	Anastrozole (Arimidex)FDA LinkGeneric 02/2009
1	Tamoxifen FDA LinkGeneric 02/2009
1	paclitaxel poliglumex (XYOTAX)IBA 09/2008
1	Dihydrotachysterol (AT 10)IBA 08/2008
1	Filgrastim (Neupogen)FDA Link 06/2007
1	Trastuzumab (Herceptin)FDA Link 01/2003
1	ErbB-2 ReceptorIBA 01/2003
1	Etoposide (VP 16)FDA LinkGeneric 11/2002
1	AlbuminsIBA 11/2002
1	recombinant BMS-191352 proteinIBA 10/2002
1	Immunotoxins (Immunotoxin)IBA 10/2002
1	CarbohydratesIBA 10/2002
1	RNA (Ribonucleic Acid)IBA 01/2002
1	DNA (Deoxyribonucleic Acid)IBA 01/2002
1	9-methoxyacridineIBA 01/2002
1	AcridinesIBA 01/2002
1	NSC 366140 (pyrazoloacridine)IBA 01/2002

Therapy/Procedure

27	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
22	Therapeutics 01/2022 - 02/2002
6	Cytoreduction Surgical Procedures 12/2019 - 12/2009
4	Adjuvant Chemotherapy 01/2019 - 10/2016
4	Radiotherapy 01/2009 - 01/2006
3	Neoadjuvant Therapy 11/2016 - 10/2016
3	Segmental Mastectomy (Lumpectomy) 08/2008 - 10/2003
1	Induction Chemotherapy 12/2019
1	Combination Drug Therapy (Combination Chemotherapy) 12/2019
1	Treatment Delay 10/2018
1	Colectomy 04/2014
1	Mastectomy (Mammectomy) 12/2008
1	TP protocol 06/2007